Core Insights - Colgate-Palmolive Company (CL) is anticipated to report a decline in earnings for Q3 2025, with revenues expected to reach $5.1 billion, reflecting a 2% increase year-over-year [1][9] Financial Performance - The consensus estimate for CL's earnings is set at 89 cents per share, indicating a 2.2% decline compared to the previous year [2][9] - In the last reported quarter, CL exceeded the consensus earnings estimate by 3.4%, with an average earnings surprise of 3.7% over the last four quarters [2] Earnings Prediction Model - The current model indicates a negative Earnings ESP of -0.61% for Colgate, with a Zacks Rank of 4 (Sell), suggesting a lower likelihood of an earnings beat this season [3] Business Momentum and Growth Drivers - Colgate's Q3 performance is expected to benefit from strong business momentum, driven by pricing strategies, funding-the-growth initiatives, and productivity improvements [4][9] - The company's focus on science-based innovation, such as the relaunch of Colgate Total and other product lines, is supporting category growth and brand penetration [5] Sales and Margin Expectations - Projected sales growth for Q3 2025 is 2.9%, with organic sales growth of 2.1%. Volume is expected to decline by 0.1%, offset by pricing gains of 2.2% [6] - Gross margin is predicted to expand by 60 basis points to 60.7% for Q3 2025, supported by strong pricing and revenue growth management initiatives [7] Regional Performance Challenges - Colgate's performance may face challenges from inflationary pressures, foreign currency fluctuations, and weak performance in key regions, particularly in Latin America [8][10] Market Performance and Valuation - Colgate's shares have decreased by 10.4% over the past three months, compared to a 5.1% decline in the industry [11] - The company trades at a forward P/E multiple of 20.18X, which is above the industry average of 19.05X and below the S&P 500's average of 23.69X, indicating a relatively high valuation [11]

Core Insights - Colgate-Palmolive Company (CL) is effectively utilizing its pricing power to drive growth and alleviate external cost pressures [1][10] - The company is focusing on productivity programs aimed at cost savings and operational efficiency [1][10] Pricing Strategy - Colgate sets competitive prices while emphasizing the value and benefits of its products, catering to various consumer budgets [2] - Key pricing actions, along with the funding-the-growth program, are enhancing efficiency and expanding margins [2] Supply Chain and Innovation - The company is optimizing its global supply chain for agility and resilience, using AI and data analytics to improve portfolio and promotional decisions [3] - Colgate prioritizes innovation as a growth driver, with recent product launches enhancing brand health and household penetration [4] Category Performance - In Oral Care, the relaunch of Colgate Total is gaining market share, particularly in Latin America and Asia [5] - Skincare brands like EltaMD and PCA Skin are also contributing to growth, supported by consumer shifts towards premium products [5] Financial Performance - Colgate's shares have decreased by 12.5% year-to-date, compared to an 8.1% decline in the industry [8] - The forward price-to-earnings ratio for CL is 20.99X, higher than the industry average of 19.09X [9] Earnings Estimates - The Zacks Consensus Estimate indicates year-over-year EPS growth of 2.2% for 2025 and 6.9% for 2026 [11] - Current estimates for EPS are stable, with a consensus of 3.68 for 2025 and 3.93 for 2026 [12]